Germany to start the first clinical tests on coronavirus vaccine

Must Read

Germany has authorized its first clinical test of a vaccine for the novel coronavirus, the country’s regulatory body said on Wednesday, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.

“The Paul-Ehrlich-Institut… has authorised the first clinical trial of a vaccine against COVID-19 in Germany,” the regulatory body said in a statement.

It added that approval was the “result of a careful assessment of the potential risk/benefit profile of the vaccine candidate”.

Stay updated

Subscribe to our newsletter and never miss an update on the latest tech, gaming, startup, how to guide, deals and more.

- Advertisement -
- Advertisement -

Latest

- Advertisement -

Related

- Advertisement -
- Advertisement -